This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08624/identifier/chebi/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB08624/identifier/pdb/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08624/identifier/pubchem-compound/
n8http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08624/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08624/identifier/drugbank/

Statements

Subject Item
n2:DB08624
rdf:type
n8:Drug
n8:group
experimental
owl:sameAs
n4:DB08624 n10:DB08624
dcterms:title
BENZOTHIAZOLE
adms:identifier
n6:DB08624 n7:THZ n12:45993 n13:46937165 n14:99445095
n8:synthesisReference
Roger J. Hopper, Budd H. Sturm, Joseph F. Geiser, "Preparation of 2-(isopropylsulfinyl)benzothiazole." U.S. Patent US4350818, issued April, 1944.
n8:IUPAC-Name
n9:271B43E8-363D-11E5-9242-09173F13E4C5
n8:InChI
n9:271B43EE-363D-11E5-9242-09173F13E4C5
n8:Molecular-Formula
n9:271B43ED-363D-11E5-9242-09173F13E4C5
n8:Molecular-Weight
n9:271B43EA-363D-11E5-9242-09173F13E4C5
n8:Monoisotopic-Weight
n9:271B43EB-363D-11E5-9242-09173F13E4C5
n8:SMILES
n9:271B43EC-363D-11E5-9242-09173F13E4C5
n8:Water-Solubility
n9:271B43E6-363D-11E5-9242-09173F13E4C5
n8:logP
n9:271B43E7-363D-11E5-9242-09173F13E4C5 n9:271B43E4-363D-11E5-9242-09173F13E4C5
n8:logS
n9:271B43E5-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Acceptor-Count
n9:271B43F4-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Donor-Count
n9:271B43F5-363D-11E5-9242-09173F13E4C5
n8:InChIKey
n9:271B43EF-363D-11E5-9242-09173F13E4C5
n8:Polar-Surface-Area--PSA-
n9:271B43F0-363D-11E5-9242-09173F13E4C5
n8:Polarizability
n9:271B43F2-363D-11E5-9242-09173F13E4C5
n8:Refractivity
n9:271B43F1-363D-11E5-9242-09173F13E4C5
n8:Rotatable-Bond-Count
n9:271B43F3-363D-11E5-9242-09173F13E4C5
n8:Bioavailability
n9:271B43FA-363D-11E5-9242-09173F13E4C5
n8:Ghose-Filter
n9:271B43FC-363D-11E5-9242-09173F13E4C5
n8:MDDR-Like-Rule
n9:271B43FD-363D-11E5-9242-09173F13E4C5
n8:Number-of-Rings
n9:271B43F9-363D-11E5-9242-09173F13E4C5
n8:Physiological-Charge
n9:271B43F8-363D-11E5-9242-09173F13E4C5
n8:Rule-of-Five
n9:271B43FB-363D-11E5-9242-09173F13E4C5
n8:Traditional-IUPAC-Name
n9:271B43E9-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-acidic-
n9:271B43F6-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-basic-
n9:271B43F7-363D-11E5-9242-09173F13E4C5